Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-05

FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Oryza pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of bupropion hydrochloride extended-release (XL) from Oryza Pharmaceuticals Inc. under an original application. The product is in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride XL (generic) (Bupropion hydrochloride)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)